Blood gas analyzers are used to measure different parameters, such as pH, blood gas (pCO2 and pO2), electrolytes, and metabolites, from the whole blood samples. Growth in number of patients being treated in ICUs, NICUs, and emergency departments; rise in number of patients suffering from chronic diseases; technological advancement in blood gas & electrolyte analyzers, and increase in number of product approvals are the major factors driving the market growth. However, complexity involved in the interpretation of data act as a restraining factor for the market growth. Increase in investment by major medical diagnostics giants and improvement in healthcare facilities in Asia-Pacific provides growth opportunities for the market.
The global blood gas and electrolyte analyzers market size was valued at was valued at $1,698.7 Million in 2020, and is estimated to reach $2,625.23 Million by 2030, growing at a CAGR of 4.4% from 2021 to 2030.
North America dominated the global market in 2021, and is estimated to continue its dominance during the forecast period. This is attributed to higher adoption for technologically advanced devices, well-equipped healthcare facilities, and rise in admission of patients in ICUs, NICUs, and emergency departments.
In detail along with the table of contents, please click on the link below:
https://www.alliedmarketresearch.com/request-sample/4608
The growth of the blood gas and electrolyte analyzers market is majorly driven due to the rise in prevalence of chronic diseases, rise in global geriatric population, and increase in awareness for early diagnosis. In addition, growing number of patients being treated in NICUs, ICUs, and emergency departments, rapid urbanization, and consumption of unhealthy food significantly boost the blood gas and electrolyte analyzers market growth.
North America accounted for a majority of the global blood gas and electrolyte analyzers market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in prevalence of chronic disease, technological advancements, presence of key players, and rise healthcare expenditure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in geriatric population, rise in R&D activities, and increase in investments in the healthcare sector in the region.
Key Findings Of The Study:
- By product type, consumables were the highest contributor to the market in 2020.
- By end user, hospitals were the highest contributor to the blood gas and electrolyte analyzers market in 2020.
- By region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Connect Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/388
Leading market players
- Instrumentation Laboratory (A Werfen Company) (U.S.)
- Siemens AG (Germany)
- Roche Diagnostics Limited (Switzerland)
- Abbott Laboratories, Inc. (U.S.)
- Nova Biomedical (U.S.)
- OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.) (U.S.)
- ERBA Diagnostics Mannheim GmbH (Germany)
- Medica Corporation (U.S.)
- Alere, Inc. (U.S.)
The global Blood Gas and Electrolyte Analyzers Market is estimated to reach USD 653.5 million by 2022.
An increase in demand for blood gas testing, growing incidence among the patients in emergency departments and critical care, increasing healthcare expenditure, increase in the change of focus towards point-of-care testing and introduction of new expertise are some of the most affecting drivers of this market.Increase in the base population will also contribute towards the growth of the market in the coming years by resulting in high occurrence rates of diseases which include cancer, respiratory disorders, diabetes, and heart-related diseases.
Furthermore, the appearance of multi-parameter monitoring device which helps in increasing test menus and rise in requirement for miniaturized devices which is expected to improve market growth over the coming period.
For example, according to the WHO, the global geriatric population of 65 years and above will help to rise from 7% in 2000 to 16% in 2050.
Benchtop analyzers with a display (LCD) are larger, with a keypad to enter information and also contains a slot for placing in a sample tube or test strip, while portable analyzers are movable thus facilitating bedside examination.
The combined analyzer market is anticipated to witness an increase in growth as a result of increasing need for analyzers which need less maintenance, further facilitating the test results for electrolyte and blood count from samples such as whole dialysate, urine, blood, serum, and plasma.End-use InsightsThe market is divided on the basis of end-use into central laboratories and point-of-care.
Industry InsightsThe global Blood Gas and Electrolyte Analyzers Market is estimated to reach USD 653.5 million by 2022.
An increase in demand for blood gas testing, growing incidence among the patients in emergency departments and critical care, increasing healthcare expenditure, increase in the change of focus towards point-of-care testing and introduction of new expertise are some of the most affecting drivers of this market.Increase in the base population will also contribute towards the growth of the market in the coming years by resulting in high occurrence rates of diseases which include cancer, respiratory disorders, diabetes, and heart-related diseases.
Furthermore, the appearance of multi-parameter monitoring device which helps in increasing test menus and rise in requirement for miniaturized devices which is expected to improve market growth over the coming period.
For example, according to the WHO, the global geriatric population of 65 years and above will help to rise from 7% in 2000 to 16% in 2050.
Benchtop analyzers with a display (LCD) are larger, with a keypad to enter information and also contains a slot for placing in a sample tube or test strip, while portable analyzers are movable thus facilitating bedside examination.
The combined analyzer market is anticipated to witness an increase in growth as a result of increasing need for analyzers which need less maintenance, further facilitating the test results for electrolyte and blood count from samples such as whole dialysate, urine, blood, serum, and plasma.End-use InsightsThe market is divided on the basis of end-use into central laboratories and point-of-care.
Blood Gas And Electrolyte Analyzers Market is estimated to reach USD 653.5 million by 2022.
An increase in demand for blood gas testing, growing incidence among the patients in emergency departments and critical care, increasing healthcare expenditure, increase in the change of focus towards point-of-care testing and introduction of new expertise are some of the most affecting drivers of this market.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/blood-gas-electrolyte-analyzers-market/request-sample The key driving factors responsible for the growth of Blood Gas And Electrolyte Analyzers market : Increase in the base population will also contribute towards the growth of the market in the coming years by resulting in high occurrence rates of diseases which include cancer, respiratory disorders, diabetes, and heart-related diseases.
Furthermore, the appearance of multi-parameter monitoring device which helps in increasing test menus and rise in requirement for miniaturized devices which is expected to improve market growth over the coming period.
For example, according to the WHO, the global geriatric population of 65 years and above will help to rise from 7% in 2000 to 16% in 2050.
Benchtop analyzers with a display (LCD) are larger, with a keypad to enter information and also contains a slot for placing in a sample tube or test strip, while portable analyzers are movable thus facilitating bedside examination.
